Clinical Trial Update: Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals [Phase 2]

View source ↗

Summary

This Phase 2 trial investigated drug-drug interactions between rifapentine and dolutegravir in people co-infected with HIV and latent TB infection; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Latent Tuberculosis Infection

Drugs mentioned

• Priftin (rifapentine)
• Tivicay (dolutegravir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection, LTBI | Phase 2 | Status: TERMINATED | Results posted: 2024-08-09